SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-08-117035
Filing Date
2008-05-16
Accepted
2008-05-16 09:58:07
Documents
9
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 1019629
2 AMENDMENT TO ROYALTY AGREEMENT dex101.htm EX-10.1 6647
3 CONVERSION AGREEMENT dex102.htm EX-10.2 7236
4 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 5973
5 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 5866
6 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 2921
7 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 2914
8 GRAPHIC g42631img01.jpg GRAPHIC 7030
9 GRAPHIC g42631img02a.jpg GRAPHIC 4276
  Complete submission text file 0001193125-08-117035.txt   1068441
Mailing Address 324 SOUTH HYDE PARK AVE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVE SUITE 350 TAMPA FL 33606 8138642562
ACCENTIA BIOPHARMACEUTICALS INC (Filer) CIK: 0001310094 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 000-51383 | Film No.: 08840514
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1